Cardiovascular Risk-Benefit Profile of Sibutramine

By Scheen A.J.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 5, 2010-10 ,pp. : 321-334

Adis International

Access to resources Recommend Favorite

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation

By Kowey Peter R.  

Drugs in R&D, Vol. 11, Iss. 1, 2011-03 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

Cardiovascular Risk Profile of Antirheumatic Agents in Patients with Osteoarthritis and Rheumatoid Arthritis

By Nurmohamed M.T.  

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1599-1609

Adis International

Access to resources Recommend Favorite

Cardiovascular safety profile of almotriptan, a new indolic derivative for the treatment of migraine

By Gras J.   Cardelus I.   Llenas J.   Palacios J.M.  

European Journal of Pharmacology, Vol. 410, Iss. 1, 2000-12 ,pp. : 53-59

Elsevier

Access to resources Recommend Favorite

The Cardiovascular Safety Profile of Renzapride, a Novel Treatment for Irritable Bowel Syndrome

By Meyers NL   Hickling RI  

The Journal of International Medical Research, Vol. 35, Iss. 6, 2007-11 ,pp. : 848-866

Field House Publishing

Access to resources Recommend Favorite